These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 27999414)

  • 1. Recent Advances in Stimuli-Responsive Release Function Drug Delivery Systems for Tumor Treatment.
    Ding C; Tong L; Feng J; Fu J
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27999414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
    Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
    Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
    Li L; Yang WW; Xu DG
    J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release.
    Raza A; Rasheed T; Nabeel F; Hayat U; Bilal M; Iqbal HMN
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30901827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive drug delivery systems for head and neck cancer therapy.
    Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L
    Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
    Saravanakumar K; Hu X; Ali DM; Wang MH
    Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.
    Song Y; Li Y; Xu Q; Liu Z
    Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimuli-responsive polymers for anti-cancer drug delivery.
    Cheng W; Gu L; Ren W; Liu Y
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():600-8. PubMed ID: 25491870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
    Ge Z; Liu S
    Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor.
    Yin Q; Shen J; Zhang Z; Yu H; Li Y
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1699-715. PubMed ID: 23611952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
    Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
    Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox/pH dual stimuli-responsive ZnO QDs-gated mesoporous silica nanoparticles as carriers in cancer therapy.
    Wang W; Wang Y; Wang Y; Gong H; Zhu H; Liu M
    IET Nanobiotechnol; 2019 Aug; 13(6):640-649. PubMed ID: 31432799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal-Organic Framework (MOF)-based Nanomaterials for Biomedical Applications.
    Luo Z; Fan S; Gu C; Liu W; Chen J; Li B; Liu J
    Curr Med Chem; 2019; 26(18):3341-3369. PubMed ID: 29446726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
    Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
    J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery.
    Zhang L; Bei HP; Piao Y; Wang Y; Yang M; Zhao X
    Chemphyschem; 2018 Aug; 19(16):1956-1964. PubMed ID: 29575338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimuli-responsive Carriers for Controlled Intracellular Drug Release.
    Sheng Y; Hu J; Shi J; Lee LJ
    Curr Med Chem; 2019; 26(13):2377-2388. PubMed ID: 28875840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy.
    Zhou Q; Zhang L; Yang T; Wu H
    Int J Nanomedicine; 2018; 13():2921-2942. PubMed ID: 29849457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.
    Karimi M; Ghasemi A; Sahandi Zangabad P; Rahighi R; Moosavi Basri SM; Mirshekari H; Amiri M; Shafaei Pishabad Z; Aslani A; Bozorgomid M; Ghosh D; Beyzavi A; Vaseghi A; Aref AR; Haghani L; Bahrami S; Hamblin MR
    Chem Soc Rev; 2016 Mar; 45(5):1457-501. PubMed ID: 26776487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.